Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|April 12, 2007
Efavirenz: a reviewSaskia M E Vrouenraets, Ferdinand W N M Wit, Jacqueline van Tongeren, et al.
AIDS (London, England)|July 10, 2010
High prevalence of reduced bone mineral density in primary HIV-1-infected menMarlous L Grijsen, Saskia M E Vrouenraets, Radjin Steingrover, et al.
Antiviral Therapy|January 30, 2003
Hyperlactataemia in HIV-infected patients: the role of NRTI-treatmentSaskia M E Vrouenraets, Marco Treskes, Rosa M Regez, et al.
The Journal of Infectious Diseases|November 14, 2012
Low bone mineral density, regardless of HIV status, in men who have sex with menMarlous L Grijsen, Saskia M E Vrouenraets, Ferdinand W N M Wit, et al.
Clinical Nephrology|March 27, 2012
A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal functionSaskia M E Vrouenraets, Christoph A Fux, Ferdinand W N M Wit, et al.
AIDS (London, England)|August 23, 2011
Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicitySaskia M E Vrouenraets, Christoph A Fux, Ferdinand W N M Wit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2023
Switching to Doravirine in cART-Experienced Patients: An Effective and Highly Tolerated Option With Substantial Cost SavingsVincent R Lanting, Piter Oosterhof, Daoud Ait Moha, et al.
Pageof 1